Skip to content

Ultrasound Combined Transcutaneous Electrical Nerve Stimulation versus Phonophoresis of Piroxicam on symptomatic Knee Osteoarthritis: A Randomized Double-blind, Controlled Comparative Study

Ultrasound Combined Transcutaneous Electrical Nerve Stimulation versus Phonophoresis of Piroxicam on Symptomatic Knee Osteoarthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20150713001
Enrollment
Unknown
Registered
2015-07-13
Start date
2012-08-21
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee pain Arthralgia of knee

Interventions

Ultrasound therapy (UT) with non&#45
drug gel combine with Trascutaneous electrical stimulation (TENS). Patients would be treated with new model of ultrasound machine that could provided the two treatment in the same time or simultaneous
painful stimulation range from 10 mA to 30 mA.,Ultrasound therapy with piroxicam gel (PhP) plus sham TENS. Sham TENS would be operated with the intensity of just above subjective sensory threshold tha
Experimental Device,Active Comparator Device
UltraTENS,PhP

Sponsors

Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients with a diagnosis of knee OA follow to the American College of Rheumatology criteria 2. Patients had a severity of mild to moderate degree of knee OA by Kellgren-Lawrence scores 3. Patients who had knee pain at 50-mm of VAS or more 4. Patients were willing to join the study and provided informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients who had a UltraTENS experience (could not blinded) 2. Patients who had a contraindication for treatment with UT or TENS 3. Patients who had a hypersensitivity to Piroxicam gel 4. Patients who had a history of surgery at knee joint 5. Patients who had an underlying disease of rheumatoid arhritis, gouty arthritis or other chronic systematic inflammatory disease.

Design outcomes

Primary

MeasureTime frame
knee pain two weeks a 100-mm VAS of knee pain

Secondary

MeasureTime frame
Knee function two weeks Western Ontario and McMaster Universities Osteoarthritis (WOMAC)

Countries

Thailand

Contacts

Public ContactJariya Boonhong

Faculty of Medicine, Chulalongkorn University

jariya_boonhong@yahoo.com+66818891355

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026